Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (165)	12/10/2003 9:03:47 PM
From: scaram(o)uche	Respond to of 411

Just after 8 a.m., Eastern? I don't remember the exact number of shares going at 10.50, but the trades just kept going, bing, bing, bing...... I'd guess that about 150K shares went off there?

To: mopgcw who wrote (165)	12/10/2003 9:25:37 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 411

8:07 to 8:09 a.m., many, many thousands of shares........ quotes.nasdaq.com edit: oh, I see what the problem is. Don't know why I typed 10.50..... I meant 12.50.

To: mopgcw who wrote (165)	12/10/2003 11:49:10 PM
From: mopgcw	Read Replies (1) \| Respond to of 411

In the "No S***" Category w/ 1st Albany: CV Therapeutics Cut to `Underperform' at Bear Stearns :CVTX US 2003-12-10 10:55 (New York) Princeton, New Jersey, Dec. 10 (Bloomberg Data) -- CV Therapeutics Inc. (CVTX US) was downgraded to ``underperform'' from ``peer perform'' by analyst Akhtar Samad at Bear Stearns & Co. And not to be left out: CV Therapeutics Cut to `Hold' at Deutsche Bank :CVTX US 2003-12-10 13:17 (New York) Princeton, New Jersey, Dec. 10 (Bloomberg Data) -- CV Therapeutics Inc. (CVTX US) was downgraded to ``hold'' from ``buy'' by analyst Dennis R Harp at Deutsche Bank. The target price is $14 per share.